# Changes of Exosomes and Biomarkers in Plasma and Alveolar Lavage Fluid of Patients With Sepsis Complicated With ARDS

> **NCT05476029** · — · UNKNOWN · sponsor: **Tianjin Nankai Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Sepsis Complicated With ARDS

## Interventions

- **DIAGNOSTIC_TEST:** Blood samples and alveolar lavage fluid were collected

## Key facts

- **NCT ID:** NCT05476029
- **Lead sponsor:** Tianjin Nankai Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-25
- **Primary completion:** 2023-05-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05476029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05476029, "Changes of Exosomes and Biomarkers in Plasma and Alveolar Lavage Fluid of Patients With Sepsis Complicated With ARDS". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05476029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*